Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 34.55
+3.10 (9.86%)
Jul 16, 2026, 1:18 PM CST
TPEX:4139 Market Cap
TPEX:4139 has a market cap or net worth of 1.42 billion as of July 15, 2026. Its market cap has increased by 19.89% in one year.
Market Cap
1.42B
Enterprise Value
1.99B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
34.55
Market Cap Chart
Since November 13, 2009, TPEX:4139's market cap has decreased from 1.56B to 1.42B, a decrease of -9.22%. That is a compound annual growth rate of -0.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 1.42B | 28.11% |
| Dec 31, 2025 | 1.10B | -19.60% |
| Dec 31, 2024 | 1.37B | -7.18% |
| Dec 29, 2023 | 1.48B | -17.73% |
| Dec 30, 2022 | 1.80B | -2.53% |
| Dec 30, 2021 | 1.85B | -26.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 515.30B |
| Caliway Biopharmaceuticals | 167.31B |
| Heron Neutron Medical | 63.46B |
| Pell Bio-Med Technology | 58.31B |
| Enimmune | 1.20B |
| AViTA | 1.19B |
| Excelsior Biopharma | 1.18B |
| NaviFUS | 1.18B |